Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 10, 2018Medical Care

Counter-Point

View Full Paper
Ask AI
Bookmark
Share

Authors

CLChristine Y. LuThe University of SydneyGSGregory E. SimonBoston UniversitySSStephen B. SoumeraiHarvard Pilgrim Health Care

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lu et al. (2018) studied this question.

synapsesocial.com/papers/6a74007dc553859489f16a6ehttps://doi.org/10.1097/mlr.0000000000000897
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Near Real-time Surveillance for Consequences of Health Policies Using Sequential Analysis2018 · 11 citations
  2. 2Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene.1987 · 90 citations
  3. 3Antidepressants and Suicide Risk: How Did Specific Information in FDA Safety Warnings Affect Treatment Patterns?2009 · 48 citations
  4. 4News Coverage of FDA Warnings on Pediatric Antidepressant Use and Suicidality2009 · 37 citations
  5. 5Persisting Decline in Depression Treatment After FDA Warnings2009 · 155 citations